Intermittent Preventive Treatment With Antimalarials in Kenyan Infants
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see whether antimalarial drugs administered at the time of
routine infant vaccinations prevents malaria and anemia in the first year of life.
Phase:
N/A
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborators:
Bill and Melinda Gates Foundation Kenya Medical Research Institute